Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. - Wikidata - wikimedia - TriplyDB

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

http://www.wikidata.org/entity/Q37829260

about

Medical management of uveitis - current trends Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Pharmacokinetics and safety of intravitreal caspofungin.Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting.Antifungal pharmacokinetics and pharmacodynamics Colletotrichum truncatum species complex: Treatment considerations and review of the literature for an unusual pathogen causing fungal keratitis and endophthalmitis Infectious endophthalmitis: review of 420 cases A rare case of endogenous Aspergillus conicus endophthalmitis in an immunocompromised patient Tissue penetration of antifungal agents.Fungal endophthalmitis.The microbiology of endophthalmitis: global trends and a local perspective.Etiological agents of fungal endophthalmitis: diagnosis and management.Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.Third case of Candida dubliniensis endogenous endophthalmitis in North America: case report and review of the literature.An Italian consensus for invasive candidiasis management (ITALIC).The role of surgical debridement in different clinical manifestations of invasive aspergillosis.Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014.Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.Risk of Fungal Endophthalmitis Associated with Cataract Surgery: A Mini-Review.Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.Multimodal imaging of refractory Candida chorioretinitis progressing to endogenous endophthalmitis.The Role of Vitrectomy in the Management of Fungal Endophthalmitis.Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study.Successful Treatment of Bilateral Endogenous Fusarium solani Endophthalmitis in a Patient with Acute Lymphocytic Leukemia.[Candida infiltrations in the iris and lens during iritis and situation after sepsis].Surgical management of fungal endophthalmitis resulting from fungal keratitis.A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model.Atypical Retinal Lesion in a Heart Transplant Patient: Investigation and Management.Infected Baerveldt Glaucoma Drainage Device by Aspergillus niger.Intravitreal liposomal amphotericin B for treatment of endogenous candida endophthalmitis.Disseminated Sporothrix brasiliensis infection with endocardial and ocular involvement in an HIV-infected patient.Fungal endophthalmitis: an unusual complication of GI surgery and endoluminal vacuum therapy.A Case of Candida albicans Endophthalmitis with No Predisposing Risk Factors and a Distant Source of Infection.Coccidioidal endophthalmitis in immunocompetent person, California, USA.Is routine ophthalmoscopy really necessary in candidemic patients?The efficacy of voriconazole in 24 ocular Fusarium infections.[Iris tumor of unknown origin].A British Ophthalmological Surveillance Unit Study on metastatic endogenous endophthalmitis.Ocular Involvement in Patients with Fungemia in an Urban Tertiary Care Center.

P2860

Q27003399-290150B1-0D0F-42B4-94DA-D04DE306CA86 Q34505582-124186DF-A48D-4BE3-92AC-408B70B69BC9 Q34597632-3256393F-4764-4F86-A492-2CD81C2527D3 Q34616918-6502A6B6-4B19-4EDA-8268-0019D2A99F1F Q35663841-F7CA3FAF-C95C-4A15-9341-CA3A3CFB5F79 Q35780107-44874E2D-D31D-4DFD-B6A3-7A79B2B872F3 Q36590751-2EA54AA2-8932-46BB-AEED-4C6FA3B1BEB8 Q36707244-AC0721C9-AA95-438B-AE4C-F2C654DE8A53 Q37544911-70458062-5E52-4FC9-86E6-A09B69A4AD5A Q37960568-CCB870B4-2289-41DF-9B52-42F6E2084390 Q38016095-C1242634-F64F-4DAF-9F2E-43C6935F6FA0 Q38148077-45C2F84D-B96D-49D4-AEC7-3D8800F4F51D Q38149163-40F4886E-C70C-4E26-9597-DFB926522315 Q38162793-19EE48C5-D58F-4475-89FD-D2C8EC002EC5 Q38165883-3AE6251B-4FC2-4D96-BC2F-5CCDCB8A259F Q38245929-2CD969B8-57D1-4F96-838E-C8946AD78183 Q38284461-404AFC88-83F2-46F1-B93F-D27F3CC29F90 Q38284463-30C788C3-2727-4F66-B926-8241709E4F9D Q38535647-3AB7C44D-FCDE-478C-BB21-711886A96C62 Q38576045-7614943B-11C7-4496-9E24-157CE58F8FF0 Q38688900-76987E12-3C50-4E56-80DB-1E504D27C48E Q38976570-0D78ACBC-4C63-4642-A81D-10A152A51A17 Q38993773-B55D8CE0-A6C1-44CF-8835-C14A5BC215EE Q39559055-90A37ACD-F716-480F-8A56-FDECEF778377 Q40066606-5E4F41A4-2633-47C3-B45D-5AFE1A9B0F1E Q40350936-E7D9F691-94AA-457C-B08E-2F085C77FB33 Q40629084-E766A6E6-72E5-4BA3-887E-3CBD48AF1915 Q40635237-3217EDD7-6A69-43E6-8C22-E5189DF878AE Q40845698-533F02E2-57C0-4B18-BA64-84B221905B13 Q40908299-FFB16CCE-F486-4A93-8BFD-5EC600FB8F51 Q41088097-F0C09B23-94CC-4356-9ACD-104759773B6E Q41436657-DD70E8DA-66CD-4F39-918A-042F0A3DD56E Q42383622-30AB2234-28B4-448C-A850-D292112DA9BE Q42428437-5624D828-2712-498D-A7B9-A1B573F94487 Q43180469-1D595EA1-3375-4251-8DFE-11AC0464B64B Q44540929-4E8A766C-16DE-4FDA-8F3C-0FA9141AEFC4 Q44732240-D18B74C3-3DF3-43FC-950D-6D085660C143 Q45242525-45992BC1-C714-437C-B2C3-28494CC35DFC Q47554301-C4923E7F-5734-4E11-9532-5F6D576357D2 Q50079468-DB6C1905-1206-42E7-98E1-70658A0A8BBD

P2860

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

http://www.wikidata.org/entity/Q37829260

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

@en

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

@nl

type

label

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

@en

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

@nl

prefLabel

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

@en

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

@nl

P1433

Q37829260-707AD483-66B2-453C-B861-1FEEF9ECF55B

P1476

Q37829260-ED7D4582-5286-44E2-B0E1-9C95FC18E50D

P2093

Q37829260-6F6CF432-D220-4D54-AE00-572C3B5B9720

Q37829260-8F4B1D04-BCCF-41E0-8261-5E1A62CFA925

Q37829260-F9888A7B-2568-4FF2-A714-43D7EB81DA1E

P2860

Q37829260-181F3CE2-ED33-41A8-AF4D-01B878B2653A

Q37829260-21A2A753-530D-4003-95A6-B2C7C6B768B0

Q37829260-2287FBBB-9732-4277-A36F-2FB046CCE27D

Q37829260-2570D691-D84D-4780-B8BA-B287A99A9BF6

Q37829260-2887F278-893C-47B6-BC9C-8A436460E754

Q37829260-2C4F275E-156B-41E8-8A6E-CFC9801612C7

Q37829260-2D6F400D-15D8-4D66-B84B-F6142CEEF1A4

Q37829260-456E598E-8BED-4814-884C-A6C83ADEDC9C

Q37829260-49753236-C224-4104-9E7C-8409FCC75A85

Q37829260-49C39DB6-2531-44D2-9C7D-A72E7C59CB95

P304

Q37829260-F072EDB4-36D3-4093-9CCB-91C0FEB7F78D

P31

Q37829260-D2E92F8A-4D91-45FC-BE21-97134AB83F83

P356

Q37829260-C03B4C43-ABBE-4ADD-9233-78904421AAFF

P407

Q37829260-CF8EAFC4-DB14-4029-BF59-5843B0566D91

P433

Q37829260-68ED4E1B-AC44-456D-861E-5CAE52D76041

P478

Q37829260-32C04D96-76BE-4473-9EDE-8AA16BD7673B

P577

Q37829260-E8C3DFA7-7CB2-4772-8574-837FFCFC4B42

P5875

Q37829260-DC6B9ADA-9790-4EB5-A411-8E1699F58109

P698

Q37829260-B8DBBEA6-D004-4BB3-BFAC-1E37475E8913

P356

P1433

Clinical Infectious Diseases

P1476

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

@en

P2093

Carol A Kauffman

http://www.w3.org/2001/XMLSchema#string

Grant M Comer

http://www.w3.org/2001/XMLSchema#string

James Riddell

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole therapeutic drug monitoring.

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Candida endophthalmitis: clinical presentation, treatment and outcome in 23 patients.

Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits.

Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling

Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.

Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.

P304

648-653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIQ204

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49760176

http://www.w3.org/2001/XMLSchema#string

P698

21239843

http://www.w3.org/2001/XMLSchema#string